Acquisition significantly increases GenCanna’s expanding bulk ingredient and finished goods operations in the United Kingdom and key European and global markets WINCHESTER, KENTUCKY — September 1, 2021— GenCanna (gencanna.com), an industry founding producer of premium full-spectrum and broad-spectrum CBD and other quality cannabinoids for bulk supply and finished goods formulation, announced today that it has acquired CBD Capital Ltd (cbd-capital.com), the leading provider of CBD distillate, isolate, and water-soluble bulk ingredients as well as white and private label services to the United Kingdom, the European Union and markets worldwide. CBD Capital CEO, Hassan Akhtar, will continue to serve in his current role. The acquisition of CBD Capital enables GenCanna to broaden its bulk CBD product offering and distribution capabilities to its overseas customers, as well as expand its formulation capabilities and business-to-business operations through CBD Capital’s network of valued partners. CBD [...]
LONDON, U.K. — March 22, 2021 — Turnkey CBD formulator, private label accelerator, and product distributor Taylor Mammon announced today that the company, established in 2018, was acquired by US-based GenCanna, a leading producer of hemp-derived, THC-free, premium CBD and other cannabinoids. The move culminates the evolution of a successful three-year relationship, in which GenCanna served, and will continue to serve, as Taylor Mammon’s primary source of CBD and other cannabinoids for infusion into brand products.
The Association for the Cannabinoid Industry (ACI) is the UK’s membership organization for businesses committed to nurturing a safe, legal and flourishing commercial cannabis extract market. “Novel foods” are defined as foods that have limited consumption history in the UK prior to May 1997. These foods do not have an established safety profile and therefore must be evaluated on toxicological, chemical, microbiological and stability parameters, prior to market approval and sale to the general public.